Results 121 to 130 of about 1,556,084 (296)

Study on the chemistry, structural activity relationships and mechanism of action of recent synthetic, natural compounds and repurposed drugs for the treatment of COVID-19: A review

open access: yesMedical and Pharmaceutical Journal
The SARS-CoV-2 virus is responsible for the coronavirus disease 2019 (COVID-19) pandemic and has triggered a global health crisis, prompting an urgent search for effective therapeutic agents.
Aishwarya Balap   +2 more
doaj   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso   +5 more
wiley   +1 more source

Viral infections with focus on mechanism of viral immune modulators

open access: yes, 2017
Tato bakalářská práce se zabývá mechanismem působení hostitelského imunitního systému proti viru a také strategií úniků virů před imunitním systémem, vstupem virů do hostitelské buňky a modulací virových imunomodulátorů, které jsou z dostupných informací
Odložilíková, Romana
core   +1 more source

Mutant p53R273H disrupts PDPK1 homodimerization and contributes to PDPK1 activation

open access: yesMolecular Oncology, EarlyView.
How mutant p53R273H drives AKT signaling is unclear. We show that p53R273H, but not wild‐type, directly binds PDPK1 via a mutation‐dependent conformational change. This interaction disrupts inhibitory PDPK1 homodimerization and enhances AKT phosphorylation.
Mei Chee Lim   +11 more
wiley   +1 more source

Force feedback linearization for higher-order electromechanical sigma-delta modulators.

open access: yes, 2006
A higher-order electromechanical sigma–delta modulator can greatly improve the signal-to-noise ratio compared with a second-order loop that only uses the sensing element as a loop filter.
Redman-White, William   +2 more
core  

Synergistic induction of avian immune gene expression by sirtuin modulators and histone methyltransferase inhibitors

open access: yes, 2022
With the parallel increase in the global demand for poultry production and rise in the threat of antimicrobial resistance, the development of novel antibiotic alternatives is integral to the security of the food-animal industry and public health ...
Whitmore, Melanie, Gin, Ashley
core  

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury

open access: yes, 2018
If idiosyncratic drug-induced liver injury (IDILI) is immune mediated, then it is logical that immune modulators may be able to affect liver injury caused by a drug.
Jack Uetrecht (1290393)   +5 more
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Emerging and Repurposed Immune System Modulators for Alzheimer’s Disease

open access: yesDrug Design, Development and Therapy
Boris Decourt,1 Katia Azarfar,1 Ellie Marie Reyna,1 Jessica Marianne Kennedy,1 Marwan N Sabbagh2,31Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center, Lubbock, TX, USA; 2Department of Neurology, Barrow Neurological ...
Decourt B   +4 more
doaj  

Home - About - Disclaimer - Privacy